[
    [
        {
            "time": "2018-01-02",
            "original_text": "How Tax Reform Affected Medtronic's 3Q18 Performance",
            "features": {
                "keywords": [
                    "Tax Reform",
                    "Medtronic",
                    "3Q18",
                    "Performance"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "How Tax Reform Affected Medtronic's 3Q18 Performance",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "Medtronic Recovers from 1H18 Disasters with Robust 3Q18 Sales",
            "features": {
                "keywords": [
                    "Medtronic",
                    "Recovery",
                    "1H18",
                    "Disasters",
                    "Robust",
                    "3Q18",
                    "Sales"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Medtronic Recovers from 1H18 Disasters with Robust 3Q18 Sales",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "What Analysts Recommend for Medtronic, Post-3Q18 Results",
            "features": {
                "keywords": [
                    "Analysts",
                    "Recommend",
                    "Medtronic",
                    "Post-3Q18",
                    "Results"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "What Analysts Recommend for Medtronic, Post-3Q18 Results",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "George Soros Just Bought These 2 Biotech Stocks. Should You?",
            "features": {
                "keywords": [
                    "George Soros",
                    "Bought",
                    "Biotech",
                    "Stocks"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "George Soros Just Bought These 2 Biotech Stocks. Should You?",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]